vs
Castellum, Inc.（CTM）与Gossamer Bio, Inc.（GOSS）财务数据对比。点击上方公司名可切换其他公司
Gossamer Bio, Inc.的季度营收约是Castellum, Inc.的1.1倍（$13.8M vs $12.6M），Castellum, Inc.净利率更高（-10.5% vs -342.3%，领先331.8%），Gossamer Bio, Inc.同比增速更快（47.1% vs 21.9%）
Castellum, Inc.是一家总部位于美国的网络安全与信息技术服务提供商，服务覆盖国防政府机构、公共部门及商业企业客户，提供威胁检测、数据保护、云安全及托管IT解决方案，助力客户防范网络风险、保护核心数字资产。
Gossamer Bio是一家临床阶段生物制药企业，专注于发现、开发和商业化用于治疗免疫、炎症和肿瘤领域重症疾病的创新疗法，推进多条自研候选药物管线进入不同临床阶段，主要面向北美及全球其他地区的医疗市场。
CTM vs GOSS — 直观对比
营收规模更大
GOSS
是对方的1.1倍
$12.6M
营收增速更快
GOSS
高出25.2%
21.9%
净利率更高
CTM
高出331.8%
-342.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.6M | $13.8M |
| 净利润 | $-1.3M | $-47.2M |
| 毛利率 | 33.9% | — |
| 营业利润率 | -11.1% | -333.6% |
| 净利率 | -10.5% | -342.3% |
| 营收同比 | 21.9% | 47.1% |
| 净利润同比 | 51.8% | -43.0% |
| 每股收益（稀释后） | $-0.02 | $-0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTMGOSS
| Q4 25 | $12.6M | $13.8M | ||
| Q3 25 | $14.6M | $13.3M | ||
| Q2 25 | $14.0M | — | ||
| Q1 25 | $11.7M | — | ||
| Q4 24 | $10.3M | — | ||
| Q3 24 | $11.6M | — | ||
| Q2 24 | $11.5M | $95.8M | ||
| Q1 24 | $11.3M | $0 |
净利润CTMGOSS
| Q4 25 | $-1.3M | $-47.2M | ||
| Q3 25 | $415.4K | $-48.2M | ||
| Q2 25 | $-322.1K | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-2.7M | — | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | $-1.8M | $49.2M | ||
| Q1 24 | $-4.1M | $-41.9M |
毛利率CTMGOSS
| Q4 25 | 33.9% | — | ||
| Q3 25 | 37.6% | — | ||
| Q2 25 | 36.1% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 40.0% | — | ||
| Q3 24 | 42.7% | — | ||
| Q2 24 | 40.6% | — | ||
| Q1 24 | 39.8% | — |
营业利润率CTMGOSS
| Q4 25 | -11.1% | -333.6% | ||
| Q3 25 | 3.0% | -369.4% | ||
| Q2 25 | -2.7% | — | ||
| Q1 25 | -12.7% | — | ||
| Q4 24 | -15.7% | — | ||
| Q3 24 | -11.9% | — | ||
| Q2 24 | -13.6% | 54.3% | ||
| Q1 24 | -23.6% | — |
净利率CTMGOSS
| Q4 25 | -10.5% | -342.3% | ||
| Q3 25 | 2.8% | -362.7% | ||
| Q2 25 | -2.3% | — | ||
| Q1 25 | -10.0% | — | ||
| Q4 24 | -26.6% | — | ||
| Q3 24 | -11.0% | — | ||
| Q2 24 | -16.0% | 51.4% | ||
| Q1 24 | -36.3% | — |
每股收益（稀释后）CTMGOSS
| Q4 25 | $-0.02 | $-0.21 | ||
| Q3 25 | $0.00 | $-0.21 | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | $-0.01 | — | ||
| Q4 24 | $-0.05 | — | ||
| Q3 24 | $-0.02 | — | ||
| Q2 24 | $-0.03 | $0.22 | ||
| Q1 24 | $-0.08 | $-0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $136.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $35.8M | $-122.8M |
| 总资产 | $41.9M | $172.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTMGOSS
| Q4 25 | — | $136.9M | ||
| Q3 25 | — | $180.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $354.5M | ||
| Q1 24 | — | $244.4M |
总债务CTMGOSS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.0M | — | ||
| Q3 24 | $8.3M | — | ||
| Q2 24 | $8.7M | — | ||
| Q1 24 | $9.0M | — |
股东权益CTMGOSS
| Q4 25 | $35.8M | $-122.8M | ||
| Q3 25 | $36.7M | $-82.3M | ||
| Q2 25 | $31.8M | — | ||
| Q1 25 | $26.1M | — | ||
| Q4 24 | $20.2M | — | ||
| Q3 24 | $12.0M | — | ||
| Q2 24 | $12.1M | $81.5M | ||
| Q1 24 | $12.8M | $26.7M |
总资产CTMGOSS
| Q4 25 | $41.9M | $172.2M | ||
| Q3 25 | $46.3M | $208.8M | ||
| Q2 25 | $43.4M | — | ||
| Q1 25 | $41.1M | — | ||
| Q4 24 | $37.8M | — | ||
| Q3 24 | $28.8M | — | ||
| Q2 24 | $29.5M | $373.4M | ||
| Q1 24 | $30.5M | $259.4M |
负债/权益比CTMGOSS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | 0.72× | — | ||
| Q1 24 | 0.70× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-661.7K | $-48.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CTMGOSS
| Q4 25 | $-661.7K | $-48.3M | ||
| Q3 25 | $1.0M | $-36.2M | ||
| Q2 25 | $214.2K | — | ||
| Q1 25 | $-2.5M | — | ||
| Q4 24 | $-394.4K | — | ||
| Q3 24 | $742.2K | — | ||
| Q2 24 | $748.6K | $116.3M | ||
| Q1 24 | $23.7K | $-52.3M |
自由现金流CTMGOSS
| Q4 25 | — | — | ||
| Q3 25 | $957.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $738.9K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率CTMGOSS
| Q4 25 | — | — | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度CTMGOSS
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | — |
现金转化率CTMGOSS
| Q4 25 | — | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.36× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
